Astellas Builds Up Antibodies Pipeline

By Business Review Editor

Pharma Deals Review: Vol 2008 Issue 91 (Table of Contents)

Published: 1 Jan-2008

DOI: 10.3833/pdr.v2008.i91.233     ISSN: 1756-7874

Section: Features



Biologics, in particular antibodies, are playing an increasingly important part in the R&D of big pharma, and it is to be expected that all of the major global players want in...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details